Bill > HB3759

This bill amends the Illinois Food, Drug and Cosmetic Act to prohibit contracts that delay the entry of a drug into the marketplace. Specifically, the bill modifies Section 3 of the existing law by expanding the range of prohibited acts to include Section 3.21a, which appears to address pharmaceutical pay-off agreements. These agreements, often called "pay-for-delay" or "reverse payment" deals, typically occur when a brand-name drug manufacturer pays a generic drug manufacturer to delay introducing a lower-cost generic version of a medication. By adding this new section and referencing it in the list of prohibited acts, the bill aims to prevent such anti-competitive practices that can keep drug prices artificially high and limit consumer access to more affordable generic medications. The change is intended to protect consumers by promoting competition in the pharmaceutical market and potentially reducing drug costs.

Health and Social Services

https://www.ilga.gov/legislation/BillStatus.asp?DocNum=3759&GAID=18&DocTypeID=HB&SessionID=114&GA=104